The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstru…

HPV InfectionHPV 16 InfectionHigh Risk HPV+8 more

~Estimated

~$10 – $7,500

QurasenseNCT07281599

Phase 2

A Single-Arm, Open-Label Clinical Phase II Trial of the Safety and Immunogenicity of PDS0101 in People Living With HIV

This study is testing the immunotherapeutic agent, PDS0101, in adults living with HIV who are also infected with human papillomavirus (HPV) type 16. The purpos…

HPV Associated CancersHIV (Human Immunodeficiency Virus)Anal Cancer+2 more

~Estimated

~$10 – $6,250

Weill Medical College of Cornell UniversityNCT07090174